WeVote

Bill

Bill

SB 512

Medical Marijuana Edibles

2025 Regular Session Introduced by Gayle Harrell

Florida bill establishing medical marijuana edible regulations for potency, labeling, and safety died in committee without advancing to a vote.

Died in Health Policy
0
WeVote Research Nonpartisan
Bill Summary · SB 512

Legislative bill overview

SB 512 would have regulated the production, labeling, and sale of medical marijuana edibles in Florida, establishing standards for potency, packaging, and consumer safety. The bill was introduced in February 2025 but died in the Health Policy Committee after being indefinitely postponed in May, never advancing to a floor vote.

Why is this important

Medical marijuana edibles represent a growing market segment in Florida's established medical cannabis program, affecting thousands of patients who use cannabis for therapeutic purposes. Clear regulatory standards for edibles can impact product safety, consumer access, and the state's ability to monitor potency and prevent accidental overconsumption, particularly among vulnerable populations.

Potential points of contention

  • Potency limits and dosing standards – Determining appropriate serving sizes and total potency caps for edibles, balancing patient access against public health concerns about accidental overdose
  • Packaging and labeling requirements – Debates over child-resistant packaging mandates and warning label specificity versus consumer convenience and cost implications for producers
  • Testing and quality control – Establishing laboratory testing protocols and oversight mechanisms adds regulatory burden and costs that could affect product pricing and market competition

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.